This study demonstrates that common pharmacy claims-based measures underestimate the effect of actual adherence on inpatient costs among patients with serious mental illness.
Edward Vytlacil, PhD
Advertisement
Articles by Edward Vytlacil, PhD
Advertisement
Latest Updated Articles
- The Cost of Adherence Mismeasurement in Serious Mental Illness: A Claims-Based Analysis
Published: May 16th 2017 | Updated:
